SCHEMBL11922802

SCHEMBL11922802

CCCCNCc1ccc(C)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.74
HRH4 Q9H3N8 1/20 0.66
HRH3 Q9Y5N1 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.61
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C19 P33261 1/20 0.59
LMNA P02545 1/20 0.58
HPGD P15428 1/20 0.51
S1PR1 P21453 5/20 0.50
S1PR3 Q99500 5/20 0.50
S1PR2 O95136 4/20 0.50
HDAC3 O15379 2/20 0.50
HDAC4 P56524 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC10 Q969S8 2/20 0.50
HDAC11 Q96DB2 2/20 0.50
HDAC8 Q9BY41 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27688883 0.98 CHRM2 (0.71) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
SCHEMBL14288543 0.92 CHRM2 (0.81) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
SCHEMBL18485193 0.92 CHRM2 (0.81) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL3665643 0.90 CHRM2 (0.79) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL5713118 0.90 CHRM2 (0.79) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL5713126 0.90 CHRM2 (0.79) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
SCHEMBL6397368 0.87 CHRM2 (0.67) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
SCHEMBL4919923 0.84 CHRM2 (0.75) CHRM2HRH4HRH3SMN1; SMN2CYP2D6
SCHEMBL13093971 0.83 HRH4 (0.66) CHRM2HRH4HRH3SMN1; SMN2CYP1A2
SCHEMBL9637156 0.83 HRH4 (0.84) CHRM2HRH4HRH3SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183607-A1 CEREBLON LIGANDS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2023-09-28 WO disclosed
EP-3233041-B1 COSMETIC PROCESS FOR ATTENUATING WRINKLES OREAL (FR) 2019-01-30 EP disclosed
US-8236965-B2 Benzimidazole derivatives and their use as a medicament IPSEN PHARMA S.A.S. (FR) 2012-08-07 US disclosed
US-20090170922-A1 Benzimidazole derivatives and their use as a medicament SOCIETE DE CONSEILS DE RECHERECHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2009-07-02 US disclosed
US-7495110-B2 Benzimidazole derivatives and their use as GnRH antagonists SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-02-24 US disclosed
US-7320993-B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents ASTELLAS DEUTSCHLAND GMBH (DE) 2008-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170922-A1 Benzimidazole derivatives and their use as a medicament GNRHR, FSHR, KISS1R CHRM2 377/4885HRH4 102/4885HRH3 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.